Table 1

Baseline clinical characterics of the study population.

IHD1

(n = 40)

IHD 2

(n = 40)

IHD 3

(n = 40)

P

Control Group

(n = 40)


Age

60 ± 15

60 ± 11

64 ± 15

NS

64 ± 10

Male

24

26

25

NS

21

Cardiovascular Risk Factors % (n)

Hypertension

80 (n = 32)

80 (n = 32)

78 (n = 31)

NS

-

Hyperlipidemia

60 (n = 24)

60 (n = 24)

53 (n = 21)

NS

-

Smoking

68 (n = 27)

75 (n = 30)

63 (n = 25)

NS

-

Positive family history of CAD

40 (16)

40 (n = 16)

35 (n = 14)

NS

-

Diabetes

20 (n = 8)

20 (n = 8)

60 (n = 24)

p = 0.001

-

OHA

15 (n = 6)

15 (n = 6)

45 (n = 18)

NS

-

Insulin

5 (n = 2)

5 (n = 2)

15 (n = 6)

NS

-

Total number of CVRFs

4.2 ± 0.8

4.3 ± 0.8

4.4 ± 0.9

NS

-

Infarct-related vessel (LAD/LCX/RCA)

19/8/13

20/10/11

20/8/12

NS

-

PTCA/Stent at the time of AMI

40/40

40/40

40/40

NS

-

Ejection fraction (%)

45 ± 10

43 ± 11

40 ± 10

NS

69 ± 9

Medication (%)

-

Aspirin

100

100

100

NS

-

Clopidogrel

100

100

100

NS

-

ACE inhibitor or AT II blocker

100

100

100

NS

-

Beta-blocker

100

100

100

NS

-

Aldosterone Antagonist

25

25

30

NS

-

Statin

100

100

100

NS

-


Ischemic heart disease (IHD), Oral hypoglycaemic agent (OHA), Coronary artery disease (CAD), Percutaneous transluminal coronary angioplasty (PTCA), Left anterior descending coronary artery (LAD), Left circumflex artery (LCX), Right coronary artery (RCA), Coronary artery disease (CAD), Cardiovascular risk factors (CVRFs), Acute myocardial infarction (AMI), None significant (NS).

Bozdag-Turan et al. Cardiovascular Diabetology 2011 10:107   doi:10.1186/1475-2840-10-107

Open Data